Daniel Bujanda, MD
Gastroenterology · Santa Fe, NMNPI 1285993501
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Boston Scientific at 40.4% of the total. Reporting peaked in 2019 at $4,031 and has fallen 71.4% since, to $1,151 in 2025. Among gastroenterology clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $48.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Johnson & Johnson$1000
- Cook Medical LLC$800
- Medtronic$758
- AbbVie$556
- Takeda Pharmaceuticals U.S.A., Inc.$347
- plus $1K from 17 others
What the payments were for
- Grants$80010%
- Travel & lodging$3,29041%
- Food & beverage$3,94749%
- Education$691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $3,275 |
| Johnson & Johnson | 36 | $1,000 |
| Cook Medical LLC | 5 | $800 |
| Medtronic | 5 | $758 |
| AbbVie | 34 | $556 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $347 |
| Pfizer | 9 | $269 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $241 |
| Phathom Pharmaceuticals, Inc. | 4 | $178 |
| Ardelyx, Inc. | 6 | $154 |
| Aimmune Therapeutics, Inc. | 4 | $83 |
| Bristol Myers Squibb | 4 | $78 |
| Gilead | 1 | $72 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Nestle Healthcare Nutrition Inc. | 3 | $48 |
| Sanofi | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Organon | 1 | $25 |
| Conmed Corporation | 1 | $21 |
| Celltrion USA Inc. | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Echosens North America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,105 in reported general payments places this provider in the 90th percentile of 81 gastroenterology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 466 | $11,536 |
| Omeprazole | 285 | $5,626 |
| Pantoprazole Sodium | 184 | $3,074 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 43 | $823 |
| Esomeprazole Magnesium | 19 | $334 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $299 |
| Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg | 14 | $266 |
| Carvedilol | 25 | $227 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Santa Fe
- Alejandra Castillo-RothSanta Fe$4K
- Tomas ValerioSanta Fe$2K
- Christopher AtkinsonSanta Fe$1K
- Antoine JakicheAlbuquerque$108K
- Fazia MirAlbuquerque$98K
- Jean-Pierre ReinholdLas Cruces$79K
- Christopher ChangAlbuquerque$51K
- Stuart WeismanAlbuquerque$19K
- Denis McCarthyAlbuquerque$17K
- Kairasp NoshirwaniLas Cruces$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.